AchamallahNS: Visual hallucinations after combining fluoxetine and dextromethorphan. Am J Psychiatry, 149:1406, 1992.
2.
BourgeoisJA, ThomasD, JohansenT, WalkerDM: Visual hallucinations associated with fluoxetine and sertraline. J Clin Psychopharmacol, 18:482–483, 1998.
3.
ColemanDE, OtaK; Hallucinations with zolpidem and fluoxetine in an impaired driver. J Paediatr Child Health, 39:637–638, 2003.
4.
CoskunM, ZorogluS: Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination. J Clin Psychopharmacol, 28:723–725, 2008.
5.
GlennonRA, TitelerM, McKenneyJD: Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci, 35:2505–2511, 1984.
6.
LauterbachEC: Dopaminergic hallucinosis with fluoxetine in Parkinson's disease. Am J Psychiatry, 150:1750, 1993.
7.
LauterbachEC: Seratonin Reuptake inhibitors, paranoia, and the ventral basal ganglia. Clin Neuropharmacol, 14:547–555, 1991
8.
OmarSJ, RobinsonD, DaviesHD, MillerTP, TinklenbergJR: Fluoxetine and visual hallucinations in dementia. Biol Psychiatry, 38:556–558, 1995.
9.
RossR: Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. Am J Psychiatry, 163:1149–1152, 2006.
10.
UngerleiderJT, PechnickRN. Hallucinogens. In: Substance abuse: A Comprehensive Textbook, 2nd ed., edited by LowinsinJ.H., RuizP., MillmanR.B., LangrodJ.G.. Baltimore: Williams & Wilkins, 285, 1992.
11.
VlesJ, FeronF, HendriksenJ, JollesJ, Van KroonenburghM, WeberW: Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit. Neuropediatrics, 34:77–80, 2003.